Cancer
Treatment strategies for advanced neuroendocrine neoplasms: current status and future prospects
Neuroendocrine neoplasms (NENs) are comparatively uncommon tumors that come up from peptidergic neurons and neuroendocrine cells. NENs are extremely heterogeneous...
Read moreLocal consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
Non-small cell lung most cancers (NSCLC), because the main reason behind cancer-related deaths, poses a severe well being difficulty worldwide1,...
Read moreAttitude towards genetic testing for breast cancer susceptibility genes and choice of prevention strategies in Chinese women with or without breast cancer
Breast most cancers (BC) is now the most typical most cancers and the fifth main explanation for cancer-associated mortality amongst...
Read moreCarnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells
SummaryGoal: Lung most cancers is the most typical reason behind cancer-related deaths worldwide. Platinum-based chemotherapy is among the most important...
Read moreAdvancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization
SummarySynthetic intelligence (AI) is considerably advancing precision drugs, significantly within the fields of immunogenomics, radiomics, and pathomics. In immunogenomics, AI...
Read moreSafety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing prospective phase II study
SummaryGoal: The function of intraoperative radiation remedy (IORT) within the administration of resectable pancreatic most cancers (RPC) stays unclear. So...
Read more
Updates to the 2024 CSCO advanced non-small cell lung cancer guidelines
Frequent driver gene mutationsQuite a few scientific research and focused therapies regarding EGFR mutations, probably the most prevalent driver mutations...
Read moreContinuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
SummaryGoal: Our earlier research have indicated doubtlessly greater proliferative exercise of tumor cells in Chinese language sufferers with mantle-cell lymphoma...
Read moreAntibody-drug conjugates in breast cancer: advances and prospects
The “World Most cancers Statistics Report 2022” estimates that there have been roughly 20 million new most cancers circumstances worldwide,...
Read moreAdvances in gut microbiota-related treatment strategies for managing colorectal cancer in humans
SummaryColorectal most cancers (CRC) is a serious contributor to international cancer-related mortality with growing incidence charges in each developed and...
Read more
© 2025 MindNell